top of page
PROVIDER-RESOURCES
Provider-Resources
US-based Physician Members will be essential in all procedures as testing on all patients and evaluations will be conducted in the USA for proper efficacy and to rule out undesirable preexisting conditions. Such participation will present additional income opportunities as well as act as a safeguard for practices wishing to offer donor-based systemic stem cell, exosomes, and other regenerative therapies which are currently not approved by or could receive greater scrutiny by the FDA in the near future.
More detailed information will be provided in a phone interview.
DISCLAIMER:
IND or Investigational New Drug applications are proprietary in nature and therefore all forthcoming FDA Approved IND Trial information and the medical conditions addressed will not be available until FDA Approved, made public and available on www.clinicaltrials.gov. A background check on all Medical Professionals and phone interviews will be required of all participants.
Sign Up to Participate
*All applicants will have a phone interview to further discuss the opportunity and qualifying candidates will be notified within 48 hours
bottom of page